86. Pulmonary arterial hypertension Clinical trials / Disease details

Clinical trials : 1,205 / Drugs : 684 - (DrugBank : 124) / Drug target genes : 100 - Drug target pathways : 193

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05208814 (ClinicalTrials.gov)	March 31, 2022	29/12/2021	a Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects	a Parallel, Open, Single-dose Administration Phase I Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients With Renal Insufficiency and Healthy Subjects	Pulmonary Arterial Hypertension;Erectile Dysfunction	Drug: TPN171H single dose	Vigonvita Life Sciences	Shanghai Institute of Materia Medica, Chinese Academy of Sciences	Completed	18 Years	70 Years	All	16	Phase 1	China
2	NCT05185011 (ClinicalTrials.gov)	December 16, 2021	22/12/2021	Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function	A Phase I Clinical Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild Liver Insufficiency, Moderate Liver Insufficiency and Normal Liver Function	Erectile Dysfunction;Pulmonary Arterial Hypertension	Drug: TPN171H	Vigonvita Life Sciences	Shanghai Institute of Materia Medica, Chinese Academy of Sciences	Completed	18 Years	65 Years	All	24	Phase 1	China